COVID-19 Impact on Global Primaquine, Market Insights and Forecast to 2026
Primaquine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Primaquine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Primaquine market is segmented into
The Primaquine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Primaquine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Primaquine Market Share Analysis
Primaquine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Primaquine business, the date to enter into the Primaquine market, Primaquine product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Primaquine market is segmented into
- Injectables
- Capsules
- Tablets
- Hospital
- Clinic
- Laboratory
- Others
The Primaquine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Primaquine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Primaquine Market Share Analysis
Primaquine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Primaquine business, the date to enter into the Primaquine market, Primaquine product introduction, recent developments, etc.
The major vendors covered:
- Cyper Pharma
- Santa Cruz Biotechnology
- Pfizer
- Summit Medical Group
1 STUDY COVERAGE
1.1 Primaquine Product Introduction
1.2 Market Segments
1.3 Key Primaquine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Primaquine Market Size Growth Rate by Type
1.4.2 Injectables
1.4.3 Capsules
1.4.4 Tablets
1.5 Market by Application
1.5.1 Global Primaquine Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Laboratory
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Primaquine Industry Impact
1.6.1 How the Covid-19 is Affecting the Primaquine Industry
1.6.1.1 Primaquine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Primaquine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Primaquine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Primaquine Market Size Estimates and Forecasts
2.1.1 Global Primaquine Revenue 2015-2026
2.1.2 Global Primaquine Sales 2015-2026
2.2 Primaquine Market Size by Region: 2020 Versus 2026
2.2.1 Global Primaquine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Primaquine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PRIMAQUINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Primaquine Sales by Manufacturers
3.1.1 Primaquine Sales by Manufacturers (2015-2020)
3.1.2 Primaquine Sales Market Share by Manufacturers (2015-2020)
3.2 Primaquine Revenue by Manufacturers
3.2.1 Primaquine Revenue by Manufacturers (2015-2020)
3.2.2 Primaquine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Primaquine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Primaquine Revenue in 2019
3.2.5 Global Primaquine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Primaquine Price by Manufacturers
3.4 Primaquine Manufacturing Base Distribution, Product Types
3.4.1 Primaquine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Primaquine Product Type
3.4.3 Date of International Manufacturers Enter into Primaquine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Primaquine Market Size by Type (2015-2020)
4.1.1 Global Primaquine Sales by Type (2015-2020)
4.1.2 Global Primaquine Revenue by Type (2015-2020)
4.1.3 Primaquine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Primaquine Market Size Forecast by Type (2021-2026)
4.2.1 Global Primaquine Sales Forecast by Type (2021-2026)
4.2.2 Global Primaquine Revenue Forecast by Type (2021-2026)
4.2.3 Primaquine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Primaquine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Primaquine Market Size by Application (2015-2020)
5.1.1 Global Primaquine Sales by Application (2015-2020)
5.1.2 Global Primaquine Revenue by Application (2015-2020)
5.1.3 Primaquine Price by Application (2015-2020)
5.2 Primaquine Market Size Forecast by Application (2021-2026)
5.2.1 Global Primaquine Sales Forecast by Application (2021-2026)
5.2.2 Global Primaquine Revenue Forecast by Application (2021-2026)
5.2.3 Global Primaquine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Primaquine by Country
6.1.1 North America Primaquine Sales by Country
6.1.2 North America Primaquine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Primaquine Market Facts & Figures by Type
6.3 North America Primaquine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Primaquine by Country
7.1.1 Europe Primaquine Sales by Country
7.1.2 Europe Primaquine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Primaquine Market Facts & Figures by Type
7.3 Europe Primaquine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Primaquine by Region
8.1.1 Asia Pacific Primaquine Sales by Region
8.1.2 Asia Pacific Primaquine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Primaquine Market Facts & Figures by Type
8.3 Asia Pacific Primaquine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Primaquine by Country
9.1.1 Latin America Primaquine Sales by Country
9.1.2 Latin America Primaquine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Primaquine Market Facts & Figures by Type
9.3 Central & South America Primaquine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Primaquine by Country
10.1.1 Middle East and Africa Primaquine Sales by Country
10.1.2 Middle East and Africa Primaquine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Primaquine Market Facts & Figures by Type
10.3 Middle East and Africa Primaquine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Cyper Pharma
11.1.1 Cyper Pharma Corporation Information
11.1.2 Cyper Pharma Description, Business Overview and Total Revenue
11.1.3 Cyper Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cyper Pharma Primaquine Products Offered
11.1.5 Cyper Pharma Recent Development
11.2 Santa Cruz Biotechnology
11.2.1 Santa Cruz Biotechnology Corporation Information
11.2.2 Santa Cruz Biotechnology Description, Business Overview and Total Revenue
11.2.3 Santa Cruz Biotechnology Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Santa Cruz Biotechnology Primaquine Products Offered
11.2.5 Santa Cruz Biotechnology Recent Development
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description, Business Overview and Total Revenue
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Primaquine Products Offered
11.3.5 Pfizer Recent Development
11.4 Summit Medical Group
11.4.1 Summit Medical Group Corporation Information
11.4.2 Summit Medical Group Description, Business Overview and Total Revenue
11.4.3 Summit Medical Group Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Summit Medical Group Primaquine Products Offered
11.4.5 Summit Medical Group Recent Development
11.1 Cyper Pharma
11.1.1 Cyper Pharma Corporation Information
11.1.2 Cyper Pharma Description, Business Overview and Total Revenue
11.1.3 Cyper Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cyper Pharma Primaquine Products Offered
11.1.5 Cyper Pharma Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Primaquine Market Estimates and Projections by Region
12.1.1 Global Primaquine Sales Forecast by Regions 2021-2026
12.1.2 Global Primaquine Revenue Forecast by Regions 2021-2026
12.2 North America Primaquine Market Size Forecast (2021-2026)
12.2.1 North America: Primaquine Sales Forecast (2021-2026)
12.2.2 North America: Primaquine Revenue Forecast (2021-2026)
12.2.3 North America: Primaquine Market Size Forecast by Country (2021-2026)
12.3 Europe Primaquine Market Size Forecast (2021-2026)
12.3.1 Europe: Primaquine Sales Forecast (2021-2026)
12.3.2 Europe: Primaquine Revenue Forecast (2021-2026)
12.3.3 Europe: Primaquine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Primaquine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Primaquine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Primaquine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Primaquine Market Size Forecast by Region (2021-2026)
12.5 Latin America Primaquine Market Size Forecast (2021-2026)
12.5.1 Latin America: Primaquine Sales Forecast (2021-2026)
12.5.2 Latin America: Primaquine Revenue Forecast (2021-2026)
12.5.3 Latin America: Primaquine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Primaquine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Primaquine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Primaquine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Primaquine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Primaquine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Primaquine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Primaquine Product Introduction
1.2 Market Segments
1.3 Key Primaquine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Primaquine Market Size Growth Rate by Type
1.4.2 Injectables
1.4.3 Capsules
1.4.4 Tablets
1.5 Market by Application
1.5.1 Global Primaquine Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Laboratory
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Primaquine Industry Impact
1.6.1 How the Covid-19 is Affecting the Primaquine Industry
1.6.1.1 Primaquine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Primaquine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Primaquine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Primaquine Market Size Estimates and Forecasts
2.1.1 Global Primaquine Revenue 2015-2026
2.1.2 Global Primaquine Sales 2015-2026
2.2 Primaquine Market Size by Region: 2020 Versus 2026
2.2.1 Global Primaquine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Primaquine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PRIMAQUINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Primaquine Sales by Manufacturers
3.1.1 Primaquine Sales by Manufacturers (2015-2020)
3.1.2 Primaquine Sales Market Share by Manufacturers (2015-2020)
3.2 Primaquine Revenue by Manufacturers
3.2.1 Primaquine Revenue by Manufacturers (2015-2020)
3.2.2 Primaquine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Primaquine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Primaquine Revenue in 2019
3.2.5 Global Primaquine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Primaquine Price by Manufacturers
3.4 Primaquine Manufacturing Base Distribution, Product Types
3.4.1 Primaquine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Primaquine Product Type
3.4.3 Date of International Manufacturers Enter into Primaquine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Primaquine Market Size by Type (2015-2020)
4.1.1 Global Primaquine Sales by Type (2015-2020)
4.1.2 Global Primaquine Revenue by Type (2015-2020)
4.1.3 Primaquine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Primaquine Market Size Forecast by Type (2021-2026)
4.2.1 Global Primaquine Sales Forecast by Type (2021-2026)
4.2.2 Global Primaquine Revenue Forecast by Type (2021-2026)
4.2.3 Primaquine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Primaquine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Primaquine Market Size by Application (2015-2020)
5.1.1 Global Primaquine Sales by Application (2015-2020)
5.1.2 Global Primaquine Revenue by Application (2015-2020)
5.1.3 Primaquine Price by Application (2015-2020)
5.2 Primaquine Market Size Forecast by Application (2021-2026)
5.2.1 Global Primaquine Sales Forecast by Application (2021-2026)
5.2.2 Global Primaquine Revenue Forecast by Application (2021-2026)
5.2.3 Global Primaquine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Primaquine by Country
6.1.1 North America Primaquine Sales by Country
6.1.2 North America Primaquine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Primaquine Market Facts & Figures by Type
6.3 North America Primaquine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Primaquine by Country
7.1.1 Europe Primaquine Sales by Country
7.1.2 Europe Primaquine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Primaquine Market Facts & Figures by Type
7.3 Europe Primaquine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Primaquine by Region
8.1.1 Asia Pacific Primaquine Sales by Region
8.1.2 Asia Pacific Primaquine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Primaquine Market Facts & Figures by Type
8.3 Asia Pacific Primaquine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Primaquine by Country
9.1.1 Latin America Primaquine Sales by Country
9.1.2 Latin America Primaquine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Primaquine Market Facts & Figures by Type
9.3 Central & South America Primaquine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Primaquine by Country
10.1.1 Middle East and Africa Primaquine Sales by Country
10.1.2 Middle East and Africa Primaquine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Primaquine Market Facts & Figures by Type
10.3 Middle East and Africa Primaquine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Cyper Pharma
11.1.1 Cyper Pharma Corporation Information
11.1.2 Cyper Pharma Description, Business Overview and Total Revenue
11.1.3 Cyper Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cyper Pharma Primaquine Products Offered
11.1.5 Cyper Pharma Recent Development
11.2 Santa Cruz Biotechnology
11.2.1 Santa Cruz Biotechnology Corporation Information
11.2.2 Santa Cruz Biotechnology Description, Business Overview and Total Revenue
11.2.3 Santa Cruz Biotechnology Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Santa Cruz Biotechnology Primaquine Products Offered
11.2.5 Santa Cruz Biotechnology Recent Development
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description, Business Overview and Total Revenue
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Primaquine Products Offered
11.3.5 Pfizer Recent Development
11.4 Summit Medical Group
11.4.1 Summit Medical Group Corporation Information
11.4.2 Summit Medical Group Description, Business Overview and Total Revenue
11.4.3 Summit Medical Group Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Summit Medical Group Primaquine Products Offered
11.4.5 Summit Medical Group Recent Development
11.1 Cyper Pharma
11.1.1 Cyper Pharma Corporation Information
11.1.2 Cyper Pharma Description, Business Overview and Total Revenue
11.1.3 Cyper Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cyper Pharma Primaquine Products Offered
11.1.5 Cyper Pharma Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Primaquine Market Estimates and Projections by Region
12.1.1 Global Primaquine Sales Forecast by Regions 2021-2026
12.1.2 Global Primaquine Revenue Forecast by Regions 2021-2026
12.2 North America Primaquine Market Size Forecast (2021-2026)
12.2.1 North America: Primaquine Sales Forecast (2021-2026)
12.2.2 North America: Primaquine Revenue Forecast (2021-2026)
12.2.3 North America: Primaquine Market Size Forecast by Country (2021-2026)
12.3 Europe Primaquine Market Size Forecast (2021-2026)
12.3.1 Europe: Primaquine Sales Forecast (2021-2026)
12.3.2 Europe: Primaquine Revenue Forecast (2021-2026)
12.3.3 Europe: Primaquine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Primaquine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Primaquine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Primaquine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Primaquine Market Size Forecast by Region (2021-2026)
12.5 Latin America Primaquine Market Size Forecast (2021-2026)
12.5.1 Latin America: Primaquine Sales Forecast (2021-2026)
12.5.2 Latin America: Primaquine Revenue Forecast (2021-2026)
12.5.3 Latin America: Primaquine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Primaquine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Primaquine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Primaquine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Primaquine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Primaquine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Primaquine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Primaquine Market Segments
Table 2. Ranking of Global Top Primaquine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Primaquine Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Injectables
Table 5. Major Manufacturers of Capsules
Table 6. Major Manufacturers of Tablets
Table 7. COVID-19 Impact Global Market: (Four Primaquine Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Primaquine Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Primaquine Players to Combat Covid-19 Impact
Table 12. Global Primaquine Market Size Growth Rate by Application 2020-2026 (K MT)
Table 13. Global Primaquine Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 14. Global Primaquine Sales by Regions 2015-2020 (K MT)
Table 15. Global Primaquine Sales Market Share by Regions (2015-2020)
Table 16. Global Primaquine Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Primaquine Sales by Manufacturers (2015-2020) (K MT)
Table 18. Global Primaquine Sales Share by Manufacturers (2015-2020)
Table 19. Global Primaquine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Primaquine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Primaquine as of 2019)
Table 21. Primaquine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Primaquine Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Primaquine Price (2015-2020) (USD/MT)
Table 24. Primaquine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Primaquine Product Type
Table 26. Date of International Manufacturers Enter into Primaquine Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Primaquine Sales by Type (2015-2020) (K MT)
Table 29. Global Primaquine Sales Share by Type (2015-2020)
Table 30. Global Primaquine Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Primaquine Revenue Share by Type (2015-2020)
Table 32. Primaquine Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 33. Global Primaquine Sales by Application (2015-2020) (K MT)
Table 34. Global Primaquine Sales Share by Application (2015-2020)
Table 35. North America Primaquine Sales by Country (2015-2020) (K MT)
Table 36. North America Primaquine Sales Market Share by Country (2015-2020)
Table 37. North America Primaquine Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Primaquine Revenue Market Share by Country (2015-2020)
Table 39. North America Primaquine Sales by Type (2015-2020) (K MT)
Table 40. North America Primaquine Sales Market Share by Type (2015-2020)
Table 41. North America Primaquine Sales by Application (2015-2020) (K MT)
Table 42. North America Primaquine Sales Market Share by Application (2015-2020)
Table 43. Europe Primaquine Sales by Country (2015-2020) (K MT)
Table 44. Europe Primaquine Sales Market Share by Country (2015-2020)
Table 45. Europe Primaquine Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Primaquine Revenue Market Share by Country (2015-2020)
Table 47. Europe Primaquine Sales by Type (2015-2020) (K MT)
Table 48. Europe Primaquine Sales Market Share by Type (2015-2020)
Table 49. Europe Primaquine Sales by Application (2015-2020) (K MT)
Table 50. Europe Primaquine Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Primaquine Sales by Region (2015-2020) (K MT)
Table 52. Asia Pacific Primaquine Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Primaquine Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Primaquine Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Primaquine Sales by Type (2015-2020) (K MT)
Table 56. Asia Pacific Primaquine Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Primaquine Sales by Application (2015-2020) (K MT)
Table 58. Asia Pacific Primaquine Sales Market Share by Application (2015-2020)
Table 59. Latin America Primaquine Sales by Country (2015-2020) (K MT)
Table 60. Latin America Primaquine Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Primaquine Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Primaquine Revenue Market Share by Country (2015-2020)
Table 63. Latin America Primaquine Sales by Type (2015-2020) (K MT)
Table 64. Latin America Primaquine Sales Market Share by Type (2015-2020)
Table 65. Latin America Primaquine Sales by Application (2015-2020) (K MT)
Table 66. Latin America Primaquine Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Primaquine Sales by Country (2015-2020) (K MT)
Table 68. Middle East and Africa Primaquine Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Primaquine Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Primaquine Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Primaquine Sales by Type (2015-2020) (K MT)
Table 72. Middle East and Africa Primaquine Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Primaquine Sales by Application (2015-2020) (K MT)
Table 74. Middle East and Africa Primaquine Sales Market Share by Application (2015-2020)
Table 75. Cyper Pharma Corporation Information
Table 76. Cyper Pharma Description and Major Businesses
Table 77. Cyper Pharma Primaquine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Cyper Pharma Product
Table 79. Cyper Pharma Recent Development
Table 80. Santa Cruz Biotechnology Corporation Information
Table 81. Santa Cruz Biotechnology Description and Major Businesses
Table 82. Santa Cruz Biotechnology Primaquine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Santa Cruz Biotechnology Product
Table 84. Santa Cruz Biotechnology Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Major Businesses
Table 87. Pfizer Primaquine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Pfizer Product
Table 89. Pfizer Recent Development
Table 90. Summit Medical Group Corporation Information
Table 91. Summit Medical Group Description and Major Businesses
Table 92. Summit Medical Group Primaquine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Summit Medical Group Product
Table 94. Summit Medical Group Recent Development
Table 95. Global Primaquine Sales Forecast by Regions (2021-2026) (K MT)
Table 96. Global Primaquine Sales Market Share Forecast by Regions (2021-2026)
Table 97. Global Primaquine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 98. Global Primaquine Revenue Market Share Forecast by Regions (2021-2026)
Table 99. North America: Primaquine Sales Forecast by Country (2021-2026) (K MT)
Table 100. North America: Primaquine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Europe: Primaquine Sales Forecast by Country (2021-2026) (K MT)
Table 102. Europe: Primaquine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Asia Pacific: Primaquine Sales Forecast by Region (2021-2026) (K MT)
Table 104. Asia Pacific: Primaquine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 105. Latin America: Primaquine Sales Forecast by Country (2021-2026) (K MT)
Table 106. Latin America: Primaquine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Middle East and Africa: Primaquine Sales Forecast by Country (2021-2026) (K MT)
Table 108. Middle East and Africa: Primaquine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 110. Key Challenges
Table 111. Market Risks
Table 112. Main Points Interviewed from Key Primaquine Players
Table 113. Primaquine Customers List
Table 114. Primaquine Distributors List
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 1. Primaquine Market Segments
Table 2. Ranking of Global Top Primaquine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Primaquine Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Injectables
Table 5. Major Manufacturers of Capsules
Table 6. Major Manufacturers of Tablets
Table 7. COVID-19 Impact Global Market: (Four Primaquine Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Primaquine Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Primaquine Players to Combat Covid-19 Impact
Table 12. Global Primaquine Market Size Growth Rate by Application 2020-2026 (K MT)
Table 13. Global Primaquine Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 14. Global Primaquine Sales by Regions 2015-2020 (K MT)
Table 15. Global Primaquine Sales Market Share by Regions (2015-2020)
Table 16. Global Primaquine Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Primaquine Sales by Manufacturers (2015-2020) (K MT)
Table 18. Global Primaquine Sales Share by Manufacturers (2015-2020)
Table 19. Global Primaquine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Primaquine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Primaquine as of 2019)
Table 21. Primaquine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Primaquine Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Primaquine Price (2015-2020) (USD/MT)
Table 24. Primaquine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Primaquine Product Type
Table 26. Date of International Manufacturers Enter into Primaquine Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Primaquine Sales by Type (2015-2020) (K MT)
Table 29. Global Primaquine Sales Share by Type (2015-2020)
Table 30. Global Primaquine Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Primaquine Revenue Share by Type (2015-2020)
Table 32. Primaquine Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 33. Global Primaquine Sales by Application (2015-2020) (K MT)
Table 34. Global Primaquine Sales Share by Application (2015-2020)
Table 35. North America Primaquine Sales by Country (2015-2020) (K MT)
Table 36. North America Primaquine Sales Market Share by Country (2015-2020)
Table 37. North America Primaquine Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Primaquine Revenue Market Share by Country (2015-2020)
Table 39. North America Primaquine Sales by Type (2015-2020) (K MT)
Table 40. North America Primaquine Sales Market Share by Type (2015-2020)
Table 41. North America Primaquine Sales by Application (2015-2020) (K MT)
Table 42. North America Primaquine Sales Market Share by Application (2015-2020)
Table 43. Europe Primaquine Sales by Country (2015-2020) (K MT)
Table 44. Europe Primaquine Sales Market Share by Country (2015-2020)
Table 45. Europe Primaquine Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Primaquine Revenue Market Share by Country (2015-2020)
Table 47. Europe Primaquine Sales by Type (2015-2020) (K MT)
Table 48. Europe Primaquine Sales Market Share by Type (2015-2020)
Table 49. Europe Primaquine Sales by Application (2015-2020) (K MT)
Table 50. Europe Primaquine Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Primaquine Sales by Region (2015-2020) (K MT)
Table 52. Asia Pacific Primaquine Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Primaquine Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Primaquine Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Primaquine Sales by Type (2015-2020) (K MT)
Table 56. Asia Pacific Primaquine Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Primaquine Sales by Application (2015-2020) (K MT)
Table 58. Asia Pacific Primaquine Sales Market Share by Application (2015-2020)
Table 59. Latin America Primaquine Sales by Country (2015-2020) (K MT)
Table 60. Latin America Primaquine Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Primaquine Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Primaquine Revenue Market Share by Country (2015-2020)
Table 63. Latin America Primaquine Sales by Type (2015-2020) (K MT)
Table 64. Latin America Primaquine Sales Market Share by Type (2015-2020)
Table 65. Latin America Primaquine Sales by Application (2015-2020) (K MT)
Table 66. Latin America Primaquine Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Primaquine Sales by Country (2015-2020) (K MT)
Table 68. Middle East and Africa Primaquine Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Primaquine Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Primaquine Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Primaquine Sales by Type (2015-2020) (K MT)
Table 72. Middle East and Africa Primaquine Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Primaquine Sales by Application (2015-2020) (K MT)
Table 74. Middle East and Africa Primaquine Sales Market Share by Application (2015-2020)
Table 75. Cyper Pharma Corporation Information
Table 76. Cyper Pharma Description and Major Businesses
Table 77. Cyper Pharma Primaquine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Cyper Pharma Product
Table 79. Cyper Pharma Recent Development
Table 80. Santa Cruz Biotechnology Corporation Information
Table 81. Santa Cruz Biotechnology Description and Major Businesses
Table 82. Santa Cruz Biotechnology Primaquine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Santa Cruz Biotechnology Product
Table 84. Santa Cruz Biotechnology Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Major Businesses
Table 87. Pfizer Primaquine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Pfizer Product
Table 89. Pfizer Recent Development
Table 90. Summit Medical Group Corporation Information
Table 91. Summit Medical Group Description and Major Businesses
Table 92. Summit Medical Group Primaquine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Summit Medical Group Product
Table 94. Summit Medical Group Recent Development
Table 95. Global Primaquine Sales Forecast by Regions (2021-2026) (K MT)
Table 96. Global Primaquine Sales Market Share Forecast by Regions (2021-2026)
Table 97. Global Primaquine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 98. Global Primaquine Revenue Market Share Forecast by Regions (2021-2026)
Table 99. North America: Primaquine Sales Forecast by Country (2021-2026) (K MT)
Table 100. North America: Primaquine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Europe: Primaquine Sales Forecast by Country (2021-2026) (K MT)
Table 102. Europe: Primaquine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Asia Pacific: Primaquine Sales Forecast by Region (2021-2026) (K MT)
Table 104. Asia Pacific: Primaquine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 105. Latin America: Primaquine Sales Forecast by Country (2021-2026) (K MT)
Table 106. Latin America: Primaquine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Middle East and Africa: Primaquine Sales Forecast by Country (2021-2026) (K MT)
Table 108. Middle East and Africa: Primaquine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 110. Key Challenges
Table 111. Market Risks
Table 112. Main Points Interviewed from Key Primaquine Players
Table 113. Primaquine Customers List
Table 114. Primaquine Distributors List
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Primaquine Product Picture
Figure 2. Global Primaquine Sales Market Share by Type in 2020 & 2026
Figure 3. Injectables Product Picture
Figure 4. Capsules Product Picture
Figure 5. Tablets Product Picture
Figure 6. Global Primaquine Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Laboratory
Figure 10. Others
Figure 11. Primaquine Report Years Considered
Figure 12. Global Primaquine Market Size 2015-2026 (US$ Million)
Figure 13. Global Primaquine Sales 2015-2026 (K MT)
Figure 14. Global Primaquine Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Primaquine Sales Market Share by Region (2015-2020)
Figure 16. Global Primaquine Sales Market Share by Region in 2019
Figure 17. Global Primaquine Revenue Market Share by Region (2015-2020)
Figure 18. Global Primaquine Revenue Market Share by Region in 2019
Figure 19. Global Primaquine Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Primaquine Revenue in 2019
Figure 21. Primaquine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Primaquine Sales Market Share by Type (2015-2020)
Figure 23. Global Primaquine Sales Market Share by Type in 2019
Figure 24. Global Primaquine Revenue Market Share by Type (2015-2020)
Figure 25. Global Primaquine Revenue Market Share by Type in 2019
Figure 26. Global Primaquine Market Share by Price Range (2015-2020)
Figure 27. Global Primaquine Sales Market Share by Application (2015-2020)
Figure 28. Global Primaquine Sales Market Share by Application in 2019
Figure 29. Global Primaquine Revenue Market Share by Application (2015-2020)
Figure 30. Global Primaquine Revenue Market Share by Application in 2019
Figure 31. North America Primaquine Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Primaquine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Primaquine Sales Market Share by Country in 2019
Figure 34. North America Primaquine Revenue Market Share by Country in 2019
Figure 35. U.S. Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Primaquine Market Share by Type in 2019
Figure 40. North America Primaquine Market Share by Application in 2019
Figure 41. Europe Primaquine Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Primaquine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Primaquine Sales Market Share by Country in 2019
Figure 44. Europe Primaquine Revenue Market Share by Country in 2019
Figure 45. Germany Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Primaquine Market Share by Type in 2019
Figure 56. Europe Primaquine Market Share by Application in 2019
Figure 57. Asia Pacific Primaquine Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Primaquine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Primaquine Sales Market Share by Region in 2019
Figure 60. Asia Pacific Primaquine Revenue Market Share by Region in 2019
Figure 61. China Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Primaquine Market Share by Type in 2019
Figure 84. Asia Pacific Primaquine Market Share by Application in 2019
Figure 85. Latin America Primaquine Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Primaquine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Primaquine Sales Market Share by Country in 2019
Figure 88. Latin America Primaquine Revenue Market Share by Country in 2019
Figure 89. Mexico Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Primaquine Market Share by Type in 2019
Figure 96. Latin America Primaquine Market Share by Application in 2019
Figure 97. Middle East and Africa Primaquine Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Primaquine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Primaquine Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Primaquine Revenue Market Share by Country in 2019
Figure 101. Turkey Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Primaquine Market Share by Type in 2019
Figure 108. Middle East and Africa Primaquine Market Share by Application in 2019
Figure 109. Cyper Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Santa Cruz Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Summit Medical Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Primaquine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. North America Primaquine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Primaquine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Europe Primaquine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Primaquine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Asia Pacific Primaquine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Primaquine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Latin America Primaquine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Primaquine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Middle East and Africa Primaquine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
Figure 1. Primaquine Product Picture
Figure 2. Global Primaquine Sales Market Share by Type in 2020 & 2026
Figure 3. Injectables Product Picture
Figure 4. Capsules Product Picture
Figure 5. Tablets Product Picture
Figure 6. Global Primaquine Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Laboratory
Figure 10. Others
Figure 11. Primaquine Report Years Considered
Figure 12. Global Primaquine Market Size 2015-2026 (US$ Million)
Figure 13. Global Primaquine Sales 2015-2026 (K MT)
Figure 14. Global Primaquine Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Primaquine Sales Market Share by Region (2015-2020)
Figure 16. Global Primaquine Sales Market Share by Region in 2019
Figure 17. Global Primaquine Revenue Market Share by Region (2015-2020)
Figure 18. Global Primaquine Revenue Market Share by Region in 2019
Figure 19. Global Primaquine Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Primaquine Revenue in 2019
Figure 21. Primaquine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Primaquine Sales Market Share by Type (2015-2020)
Figure 23. Global Primaquine Sales Market Share by Type in 2019
Figure 24. Global Primaquine Revenue Market Share by Type (2015-2020)
Figure 25. Global Primaquine Revenue Market Share by Type in 2019
Figure 26. Global Primaquine Market Share by Price Range (2015-2020)
Figure 27. Global Primaquine Sales Market Share by Application (2015-2020)
Figure 28. Global Primaquine Sales Market Share by Application in 2019
Figure 29. Global Primaquine Revenue Market Share by Application (2015-2020)
Figure 30. Global Primaquine Revenue Market Share by Application in 2019
Figure 31. North America Primaquine Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Primaquine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Primaquine Sales Market Share by Country in 2019
Figure 34. North America Primaquine Revenue Market Share by Country in 2019
Figure 35. U.S. Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Primaquine Market Share by Type in 2019
Figure 40. North America Primaquine Market Share by Application in 2019
Figure 41. Europe Primaquine Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Primaquine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Primaquine Sales Market Share by Country in 2019
Figure 44. Europe Primaquine Revenue Market Share by Country in 2019
Figure 45. Germany Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Primaquine Market Share by Type in 2019
Figure 56. Europe Primaquine Market Share by Application in 2019
Figure 57. Asia Pacific Primaquine Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Primaquine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Primaquine Sales Market Share by Region in 2019
Figure 60. Asia Pacific Primaquine Revenue Market Share by Region in 2019
Figure 61. China Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Primaquine Market Share by Type in 2019
Figure 84. Asia Pacific Primaquine Market Share by Application in 2019
Figure 85. Latin America Primaquine Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Primaquine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Primaquine Sales Market Share by Country in 2019
Figure 88. Latin America Primaquine Revenue Market Share by Country in 2019
Figure 89. Mexico Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Primaquine Market Share by Type in 2019
Figure 96. Latin America Primaquine Market Share by Application in 2019
Figure 97. Middle East and Africa Primaquine Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Primaquine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Primaquine Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Primaquine Revenue Market Share by Country in 2019
Figure 101. Turkey Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Primaquine Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Primaquine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Primaquine Market Share by Type in 2019
Figure 108. Middle East and Africa Primaquine Market Share by Application in 2019
Figure 109. Cyper Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Santa Cruz Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Summit Medical Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Primaquine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. North America Primaquine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Primaquine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Europe Primaquine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Primaquine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Asia Pacific Primaquine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Primaquine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Latin America Primaquine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Primaquine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Middle East and Africa Primaquine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
